Jefferies & Company
JEF
$57.13
+5.87%
Jefferies Financial Group is a full-service investment banking and capital markets firm, providing advisory, underwriting, and trading services primarily to middle-market clients in North America. Founded in 1962 and transformed through its 2013 merger with Leucadia, the company has evolved from a holding company into a focused investment bank, capturing significant market share over the past decade. The current investor narrative centers on Jefferies' ability to sustain revenue growth amid a volatile capital markets environment, with recent quarterly results showing a 16.1% YoY revenue increase driven by strong investment banking and principal transactions. Attention is also on the stock's sharp recovery from its 52-week low, as analysts debate whether the rebound reflects a cyclical upturn or sustainable margin expansion.…
JEF
Jefferies & Company
$57.13
Related headlines
Investment Opinion: Should I buy JEF Today?
Rating: Buy. Jefferies offers a compelling risk/reward at current levels, with a forward P/E of 11.59x pricing in a strong earnings recovery that is already materializing in Q1 2026 results. The consensus analyst rating is Buy, with an average EPS estimate of $3.17, implying 21.6% growth from trailing EPS. The stock's discounted valuation relative to its 5-year average P/E of ~20x provides a margin of safety.
Supporting evidence: (1) Revenue grew 16.1% YoY in Q1 2026, accelerating from 3.4% in Q4 2025. (2) Gross margin expanded to 70.25% from 59.88% a year ago, showing operating leverage. (3) Forward P/E of 11.59x is well below the industry average of ~15-18x and the stock's historical average. (4) Net income rose 21.6% YoY to $175M, with EPS of $0.72 vs. $0.60 a year ago. (5) The stock trades at 1.16x book value, near the low end of its 5-year range (0.72x-1.67x), suggesting asset value support.
Risks & Conditions: The biggest risks are negative free cash flow (-$1.71B TTM) and high debt-to-equity (2.25x), which could pressure the balance sheet if revenue growth stalls. This Buy rating would be downgraded to Hold if revenue growth decelerates below 10% or if forward P/E expands above 15x without corresponding earnings beats. Upgrade to Strong Buy if the company generates positive FCF and net margin exceeds 8%. Overall, Jefferies appears undervalued relative to its growth trajectory and historical valuation, offering a favorable entry point for investors willing to tolerate cyclical volatility.
Sign up to view all
JEF 12-Month Price Forecast
The AI assessment is bullish with medium confidence. Jefferies' recent financial performance shows strong momentum: revenue growth is accelerating, margins are expanding, and the forward valuation is deeply discounted relative to peers and history. The key risk is the negative free cash flow and high leverage, which could become problematic in a downturn. However, the current valuation already prices in significant caution, providing a favorable risk/reward. The limited analyst coverage creates an opportunity for positive surprises as the recovery story gains recognition. We would upgrade to high confidence if the company reports positive FCF in the next quarter or if revenue growth exceeds 15% again.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Jefferies & Company's 12-month outlook, with a consensus price target around $74.27 and implied upside of +30.0% versus the current price.
Average Target
$74.27
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$46 - $74
Analyst target range
Only 2 analysts cover Jefferies, which is limited coverage for a mid-cap stock. The consensus recommendation is bullish, with ratings including Buy from Goldman Sachs and Outperform from Oppenheimer, and no Sell ratings. The average estimated EPS is $3.17, with a low of $2.87 and high of $3.57. The average revenue estimate is $10.10 billion, with a range of $9.37 billion to $11.09 billion. Based on the forward P/E of 11.59x and current price of $52.62, the implied upside to the average EPS target is not directly calculable without a target price, but the forward P/E suggests the stock is cheap relative to expected earnings. The limited coverage means the stock may be less efficiently priced, offering opportunities for active investors. The target range for EPS ($2.87 to $3.57) implies a spread of 24%, indicating moderate uncertainty about near-term earnings. The high estimate assumes continued revenue growth and margin expansion, while the low estimate may reflect concerns about market volatility or competitive pressures. Recent institutional ratings show upgrades: Morgan Stanley upgraded from Equal Weight to Overweight in December 2025, and Goldman Sachs reiterated Buy in March 2026. This positive rating momentum supports the bullish consensus. However, with only 2 analysts, investors should seek additional independent research to validate the thesis.
Bulls vs Bears: JEF Investment Factors
Jefferies presents a compelling recovery story with accelerating revenue growth, expanding margins, and a cheap forward P/E of 11.59x that prices in significant earnings improvement. The bull case is supported by strong Q1 2026 results, positive analyst sentiment, and a discounted valuation relative to history and peers. However, bears point to negative free cash flow, high leverage, limited coverage, and cyclical earnings risk. The single most important tension is whether the revenue and margin momentum can sustain through a potential macro slowdown—if it does, the stock could re-rate higher; if not, the high debt load and negative FCF could lead to a sharp de-rating. Currently, the bull case has stronger evidence given the improving fundamentals and attractive valuation.
Bullish
- Strong Revenue Growth Acceleration: Q1 2026 revenue grew 16.1% YoY to $2.87B, accelerating from 3.4% growth in the prior quarter, driven by investment banking ($1.19B) and principal transactions ($378M). This momentum suggests Jefferies is gaining market share in middle-market advisory and trading.
- Significant Margin Expansion: Gross margin improved to 70.25% in Q1 2026 from 59.88% a year ago, while operating margin rose to 7.39% from 6.11%. This indicates operating leverage as revenue grows, with a favorable mix shift toward higher-margin advisory and trading services.
- Attractive Forward Valuation: Forward P/E of 11.59x is well below the industry average of ~15-18x and the stock's 5-year average trailing P/E of ~20x. This discount implies the market is not fully pricing in the expected earnings rebound, offering upside if estimates are met.
- Positive Analyst Sentiment: Both covering analysts rate the stock Buy/Outperform, with recent upgrades from Morgan Stanley (to Overweight in Dec 2025) and reiterated Buy from Goldman Sachs. The average EPS estimate of $3.17 suggests 21.6% growth from trailing EPS of $2.61.
Bearish
- Negative Free Cash Flow: TTM free cash flow is -$1.71B, driven by working capital swings in the trading business. While partly timing-related, persistent negative FCF could pressure the balance sheet if revenue growth stalls or capital markets deteriorate.
- High Debt-to-Equity Ratio: Debt-to-equity of 2.25x is elevated, typical for investment banks but amplifying downside risk in a downturn. Interest expense of $854M in Q1 2026 consumed a significant portion of operating income, leaving less room for error.
- Limited Analyst Coverage: Only 2 analysts cover the stock, leading to less efficient pricing and higher information risk. The wide EPS estimate range ($2.87-$3.57) reflects uncertainty about near-term earnings trajectory.
- Underperformance vs. S&P 500: Stock returned -7.06% over the past year vs. S&P 500's +19.1%, and the 48.81% maximum drawdown highlights extreme volatility. This underperformance may persist if the capital markets recovery falters.
JEF Technical Analysis
Jefferies is in a recovery uptrend after a severe drawdown, with the stock trading at $52.62 as of July 2, 2026, down 7.06% over the past year but well above its 52-week low of $35.53. The current price sits at 74.1% of the 52-week range ($35.53–$71.04), indicating a rebound from the lows but still below the highs. This positioning suggests the stock has regained momentum but has not yet reached overbought territory, leaving room for further upside if the trend continues. The 1-year price change of -7.06% underperforms the S&P 500's +19.1% gain, reflecting the stock's earlier decline, but the recent recovery is narrowing the gap. Short-term momentum is mixed: the 1-month price change is -2.99%, while the 3-month change is +26.28%, showing a strong recovery over the past quarter but a slight pullback in the last month. This divergence—strong 3-month gains versus a recent 1-month dip—could signal a temporary consolidation after a sharp rally, rather than a trend reversal. The relative strength over 3 months is +12.72% versus the S&P 500, indicating outperformance during the recovery phase. The 52-week high of $71.04 represents key resistance, while the 52-week low of $35.53 is the major support level. A breakout above $71.04 would signal a resumption of the long-term uptrend and could target new highs, while a breakdown below $35.53 would indicate a failure of the recovery and potential further downside. The stock's beta is not provided, but its 48.81% maximum drawdown over the period suggests high volatility, consistent with a mid-cap financial stock. The current ratio of 2.43 indicates strong liquidity, but the debt-to-equity ratio of 2.25 implies significant leverage, amplifying both upside and downside moves.
Beta
—
—
Max Drawdown
-48.8%
Largest decline past year
52-Week Range
$36-$71
Price range past year
Annual Return
+4.2%
Cumulative gain past year
| Period | JEF Return | S&P 500 |
|---|---|---|
| 1m | -7.8% | +0.0% |
| 3m | +22.7% | +7.6% |
| 6m | -10.0% | +9.1% |
| 1y | +4.2% | +21.3% |
| ytd | -10.0% | +10.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
JEF Fundamental Analysis
Jefferies' revenue trajectory is growing, with the most recent quarter (Q1 2026, ended February 28, 2026) reporting $2.87 billion, up 16.1% year-over-year from $2.47 billion in Q1 2025. This marks an acceleration from the prior quarter's 3.4% YoY growth (Q4 2025: $2.95 billion vs. $2.85 billion in Q4 2024). Revenue growth has been driven by investment banking ($1.19 billion, the largest segment) and principal transactions ($378 million), while interest revenue ($832 million) also contributed. The multi-quarter trend shows revenue rising from $2.47 billion in Q1 2025 to $2.87 billion in Q1 2026, indicating a steady upward trajectory. The company is profitable, with net income of $175 million in Q1 2026, up from $144 million in Q1 2025, a 21.6% increase. Gross margin improved to 70.25% from 59.88% a year ago, reflecting a favorable revenue mix shift toward higher-margin advisory and trading. Operating margin was 7.39%, up from 6.11% in Q1 2025, while net margin improved to 6.10% from 5.82%. These margin expansions suggest operating leverage is improving as revenue grows. Jefferies has a debt-to-equity ratio of 2.25, indicating moderate leverage typical for investment banks. Free cash flow (TTM) is negative at -$1.71 billion, primarily due to working capital swings in the trading business, but operating cash flow in Q1 2026 was $1.96 billion, showing strong cash generation from operations. The current ratio of 2.43 indicates ample short-term liquidity. Return on equity (TTM) is 6.72%, below the industry average for investment banks, but improving from prior periods. The negative free cash flow is a concern, but it is largely driven by timing differences in trading receivables and payables, not a structural deficit.
Quarterly Revenue
$2.9B
2026-02
Revenue YoY Growth
+16.1%
YoY Comparison
Gross Margin
70.3%
Latest Quarter
Free Cash Flow
$-1.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is JEF Overvalued?
Since net income is positive ($175 million in Q1 2026), the primary valuation metric is the P/E ratio. The trailing P/E is 19.43x, while the forward P/E is 11.59x, based on estimated EPS of $3.17. The wide gap between trailing and forward P/E implies the market expects significant earnings growth in the coming year, consistent with the recovery narrative. Compared to the industry average for capital markets firms (not provided explicitly, but typically around 15x-18x trailing earnings), Jefferies' trailing P/E of 19.43x is slightly above the sector median, suggesting a modest premium. However, the forward P/E of 11.59x is well below the industry average, indicating that the market is pricing in a sharp earnings rebound. This discount may be justified by the company's improving margins and revenue growth trajectory. Historically, Jefferies' trailing P/E has ranged from 5.68x (Q3 2021) to 147.12x (Q2 2023), with the current 19.43x near the middle of that range. The current P/E is below the 5-year average of approximately 20x, suggesting the stock is not overvalued relative to its own history. The price-to-book ratio of 1.16x is near the lower end of its historical range (0.72x to 1.67x over the past 5 years), indicating the stock trades at a discount to book value compared to historical norms. This could imply the market is not fully valuing the company's assets, possibly due to the recent earnings volatility.
PE
19.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 6x~147x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
20.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Jefferies' high debt-to-equity ratio of 2.25x and negative TTM free cash flow of -$1.71B are key financial risks. The debt burden is typical for investment banks but amplifies earnings volatility—interest expense of $854M in Q1 2026 consumed over 400% of net income, leaving little cushion if revenue declines. The negative FCF, while partly due to working capital timing, could become structural if trading volumes normalize at lower levels. Additionally, net margin of 6.10% is thin, meaning small revenue shortfalls can disproportionately impact profitability. The 48.81% max drawdown over the period demonstrates the stock's high sensitivity to earnings shocks.
Market & Competitive Risks: Jefferies trades at a trailing P/E of 19.43x, slightly above the capital markets industry median of ~15-18x, leaving limited room for multiple expansion if growth disappoints. The stock's beta is not provided, but its 48.81% drawdown suggests high market correlation, making it vulnerable to sector rotation away from financials or a broad market downturn. Competitive risks include larger rivals like Goldman Sachs and Morgan Stanley dominating the bulge-bracket space, though Jefferies' middle-market focus provides some insulation. Recent news of IPOs and M&A activity (e.g., Suja Life IPO) signals healthy deal flow, but a sustained slowdown in capital markets could pressure advisory and underwriting fees.
Worst-Case Scenario: In a severe recession with falling M&A volumes and rising credit losses, Jefferies could see revenue decline 20-30% and margins compress to near zero. The 52-week low of $35.53 represents a 32.5% downside from the current price of $52.62. If the company also cuts its dividend (current yield 3.05%), the stock could fall further. Historical max drawdown of 48.81% implies a potential decline to ~$27, representing a 49% loss from current levels. This scenario would require a sustained bear market in financials and a sharp drop in investment banking activity.
FAQ
The key risks are: (1) Financial risk: Negative TTM free cash flow of -$1.71B and debt-to-equity of 2.25x could strain the balance sheet if revenue declines. (2) Cyclical risk: Investment banking revenue is highly sensitive to M&A and IPO volumes; a recession could cause a 20-30% revenue drop. (3) Valuation risk: The trailing P/E of 19.43x is above the industry median, leaving limited room for multiple expansion if growth disappoints. (4) Coverage risk: Only 2 analysts cover the stock, leading to less efficient pricing and potential for negative surprises. The most severe risk is a macro downturn that triggers a de-rating to a forward P/E of 8x, implying a 30%+ downside from current levels.
The 12-month forecast is moderately bullish. The base case (45% probability) sees the stock trading in the $55-$65 range, reflecting steady revenue growth of 10-12% and a forward P/E of 12-13x. The bull case (30% probability) targets $65-$75, driven by sustained 15%+ growth and multiple expansion to 15x. The bear case (25% probability) sees a decline to $36-$45 if a recession hits, with revenue falling 10-15% and P/E compressing to 8-10x. The most likely scenario is the base case, assuming capital markets remain healthy. The average analyst EPS estimate of $3.17 supports a target price of ~$57 using a 18x multiple (industry average), implying 8% upside from the current $52.62.
JEF appears undervalued based on forward earnings and book value. The forward P/E of 11.59x is well below the capital markets industry average of 15-18x and the stock's 5-year average trailing P/E of ~20x. The price-to-book ratio of 1.16x is near the low end of its 5-year range (0.72x-1.67x), suggesting the market is not fully valuing the company's assets. The trailing P/E of 19.43x is slightly above the industry median, but this is due to depressed trailing earnings. The valuation implies the market expects a sharp earnings rebound, which is already materializing. Overall, the stock is undervalued relative to its growth trajectory and historical norms.
JEF appears to be a good buy for investors with a cyclical growth tilt and a 12-18 month horizon. The stock offers a forward P/E of 11.59x, a 40% discount to the industry average, with revenue accelerating 16.1% YoY and margins expanding. Analyst consensus is Buy, and the average EPS estimate of $3.17 implies 21.6% growth. The biggest downside risk is negative free cash flow of -$1.71B TTM, which could pressure the stock if revenue growth stalls. For risk-tolerant investors, the current valuation provides a margin of safety; for conservative investors, waiting for positive FCF or a pullback to the 52-week low of $35.53 may be prudent.
JEF is better suited for a medium-term investment horizon of 12-24 months, given its cyclical nature and recovery narrative. The stock's 48.81% max drawdown and -7.06% 1-year return highlight its volatility, making it less ideal for short-term trading. The dividend yield of 3.05% provides some income, but the payout ratio of 52.7% is moderate. For long-term investors, the cyclicality means timing entry is important—buying at trough valuations (like now) can yield strong returns over a full cycle. However, the high debt and negative FCF make it riskier for a pure long-term hold. A suggested minimum holding period is 12 months to allow the recovery thesis to play out.